메뉴 건너뛰기




Volumn 32, Issue 2, 2007, Pages

Cross-reactivity of ACE inhibitor-Induced angioedema with ARBs

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TELMISARTAN;

EID: 48249110728     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (30)
  • 1
    • 33746862566 scopus 로고    scopus 로고
    • Overview of randomised trials of ACE inhibitors
    • Remuzzi G, Ruggenenti P. Overview of randomised trials of ACE inhibitors. Lancet. 2006;368:555-556.
    • (2006) Lancet , vol.368 , pp. 555-556
    • Remuzzi, G.1    Ruggenenti, P.2
  • 2
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-860.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3
  • 3
    • 28844504752 scopus 로고    scopus 로고
    • Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis
    • Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet. 2005;366:2026-2033.
    • (2005) Lancet , vol.366 , pp. 2026-2033
    • Casas, J.P.1    Chua, W.2    Loukogeorgakis, S.3
  • 4
    • 0037165228 scopus 로고    scopus 로고
    • Angiotensin II and trials of cardiovascular outcomes
    • Sleight P. Angiotensin II and trials of cardiovascular outcomes. Am J Cardiol. 2002;89:11A-16A.
    • (2002) Am J Cardiol , vol.89
    • Sleight, P.1
  • 5
    • 18544369738 scopus 로고    scopus 로고
    • The cardiovascular continuum and renin-angiotensin-aldosterone system blockade
    • Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens Suppl. 2005;23:S9-S17.
    • (2005) J Hypertens Suppl , vol.23
    • Dzau, V.1
  • 6
    • 0026762669 scopus 로고
    • Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology
    • Israili ZH, Hall W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117:234-242.
    • (1992) Ann Intern Med , vol.117 , pp. 234-242
    • Israili, Z.H.1    Hall, W.2
  • 7
    • 0036708218 scopus 로고    scopus 로고
    • Angiotensin II receptor blocker-associated angioedema: On the heels of ACE inhibitor angioedema
    • Abdi R, Dong VM, Lee CJ, et al. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy. 2002;22:1173-1175.
    • (2002) Pharmacotherapy , vol.22 , pp. 1173-1175
    • Abdi, R.1    Dong, V.M.2    Lee, C.J.3
  • 8
    • 28344443071 scopus 로고    scopus 로고
    • Tolerability and quality of life in ARB-treated patients
    • Tolerability and quality of life in ARB-treated patients. Am J Manag Care. 2005;11:S392-S394.
    • (2005) Am J Manag Care , vol.11
  • 9
    • 0031937154 scopus 로고    scopus 로고
    • ACE inhibitor-induced angioedema. Incidence, prevention, and management
    • Vleeming W, Van Amsterdam JG, Stricker BH, de Wilt DJ. ACE inhibitor-induced angioedema. Incidence, prevention, and management. Drug Saf. 1998;18:171-188.
    • (1998) Drug Saf , vol.18 , pp. 171-188
    • Vleeming, W.1    Van Amsterdam, J.G.2    Stricker, B.H.3    de Wilt, D.J.4
  • 10
    • 0034790379 scopus 로고    scopus 로고
    • Angioedema associated with angiotensin II receptor antagonists: Challenging our knowledge of angioedema and its etiology
    • Chiu AG, Krowiak EJ, Deeb ZE. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope. 2001;111:1729-1731.
    • (2001) Laryngoscope , vol.111 , pp. 1729-1731
    • Chiu, A.G.1    Krowiak, E.J.2    Deeb, Z.E.3
  • 11
    • 0028935595 scopus 로고
    • Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
    • Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol. 1995;75:793-795.
    • (1995) Am J Cardiol , vol.75 , pp. 793-795
    • Goldberg, A.I.1    Dunlay, M.C.2    Sweet, C.S.3
  • 12
    • 0028589122 scopus 로고
    • Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group
    • Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens. 1994;12:1387-1393.
    • (1994) J Hypertens , vol.12 , pp. 1387-1393
    • Lacourciere, Y.1    Brunner, H.2    Irwin, R.3
  • 15
    • 33947732173 scopus 로고    scopus 로고
    • Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implications
    • Sarkar P, Nicholson G, Hall G. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anaesth. 2006;53:994-1003.
    • (2006) Can J Anaesth , vol.53 , pp. 994-1003
    • Sarkar, P.1    Nicholson, G.2    Hall, G.3
  • 16
    • 33750583287 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor-associated angioedema
    • Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006;26:725-737.
    • (2006) Immunol Allergy Clin North Am , vol.26 , pp. 725-737
    • Byrd, J.B.1    Adam, A.2    Brown, N.J.3
  • 17
    • 29244463522 scopus 로고    scopus 로고
    • Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists
    • Johnsen SP, Jacobsen J, Monster TB, et al. Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists. Am J Med. 2005; 118:1428-1429.
    • (2005) Am J Med , vol.118 , pp. 1428-1429
    • Johnsen, S.P.1    Jacobsen, J.2    Monster, T.B.3
  • 18
    • 0034947385 scopus 로고    scopus 로고
    • Drug-induced angioedema without urticaria
    • Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24:599-606.
    • (2001) Drug Saf , vol.24 , pp. 599-606
    • Agostoni, A.1    Cicardi, M.2
  • 19
    • 4043104220 scopus 로고    scopus 로고
    • Use of angiotensin receptor antagonists in patients with ACE inhibitor-induced angioedema
    • Fuchs SA, Meyboorn RH, van Puijenbroek EP, Guchelaar HJ. Use of angiotensin receptor antagonists in patients with ACE inhibitor-induced angioedema. Pharm World Sci. 2004;26:191-192.
    • (2004) Pharm World Sci , vol.26 , pp. 191-192
    • Fuchs, S.A.1    Meyboorn, R.H.2    van Puijenbroek, E.P.3    Guchelaar, H.J.4
  • 20
    • 0038102714 scopus 로고    scopus 로고
    • Valsartan-induced angioedema
    • Irons BK, Kumar A. Valsartan-induced angioedema. Ann Pharmacother. 2003;37:1024-1027.
    • (2003) Ann Pharmacother , vol.37 , pp. 1024-1027
    • Irons, B.K.1    Kumar, A.2
  • 21
    • 0034112556 scopus 로고    scopus 로고
    • Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema
    • Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother. 2000; 34:526-528.
    • (2000) Ann Pharmacother , vol.34 , pp. 526-528
    • Warner, K.K.1    Visconti, J.A.2    Tschampel, M.M.3
  • 22
    • 1642452758 scopus 로고    scopus 로고
    • Omapatrilat and enalapril in patients with hypertension: The Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial
    • Kostis JB, Packer M, Black HR, et al, Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004;17:103-111.
    • (2004) Am J Hypertens , vol.17 , pp. 103-111
    • Kostis, J.B.1    Packer, M.2    Black, H.R.3
  • 23
  • 24
    • 1942437363 scopus 로고    scopus 로고
    • Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment
    • Cicardi M, Zingale LC, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164:910-913.
    • (2004) Arch Intern Med , vol.164 , pp. 910-913
    • Cicardi, M.1    Zingale, L.C.2    Bergamaschini, L.3
  • 25
    • 0041909380 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting- enzyme inhibitors: The CHARM-Alternative trial
    • Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting- enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.B.1    McMurray, J.J.2    Yusuf, S.3
  • 26
    • 0038777134 scopus 로고    scopus 로고
    • The ongoing telmisartan alone and in combination with ramipril global endpoint trial program
    • Unger T. The ongoing telmisartan alone and in combination with ramipril global endpoint trial program. Am J Cardiol. 2003;91:28G-34G.
    • (2003) Am J Cardiol , vol.91
    • Unger, T.1
  • 27
    • 28744446343 scopus 로고    scopus 로고
    • Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112:e154-e235.
    • Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112:e154-e235.
  • 28
    • 10944239058 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with AcuteMyocardial Infarction)
    • Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with AcuteMyocardial Infarction). Circulation. 2004; 110: e82-e292.
    • (2004) Circulation , vol.110
    • Antman, E.M.1    Anbe, D.T.2    Armstrong, P.W.3
  • 29
    • 33646828142 scopus 로고    scopus 로고
    • AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute
    • Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2130-2139
    • Smith Jr, S.C.1    Allen, J.2    Blair, S.N.3
  • 30
    • 3042819708 scopus 로고    scopus 로고
    • National Heart, Lung, and Blood Institute; Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
    • AHA; ACC; National Heart, Lung, and Blood Institute; Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1-S290.
    • (2004) Am J Kidney Dis , vol.43 , Issue.5 SUPPL. 1
    • AHA, A.C.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.